- 2024-08-20 01:44抑制剂Adavosertib|Adavosertib|955365-80-7|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:44抑制剂ACY-775|ACY-775|1375466-18-4|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:44抑制剂Adagrasib|Adagrasib|2326521-71-3|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:44抑制剂Adagrasib|Adagrasib|2326521-71-3|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:44抑制剂ACSS2-IN-2|ACSS2-IN-2|2332820-04-7|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:44抑制剂ACSS2-IN-2|ACSS2-IN-2|2332820-04-7|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:44抑制剂ACY-775|ACY-775|1375466-18-4|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:44抑制剂ACY-775|ACY-775|1375466-18-4|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:44抑制剂Acoltremon|Acoltremon|68489-09-8|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:44抑制剂Acoltremon|Acoltremon|68489-09-8|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:44抑制剂Acoltremon|Acoltremon|68489-09-8|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:44抑制剂ACSS2-IN-2|ACSS2-IN-2|2332820-04-7|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:44抑制剂AChE-IN-27|AChE-IN-27|177028-90-9|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:44抑制剂AChE-IN-27|AChE-IN-27|177028-90-9|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:44抑制剂AChE-IN-27|AChE-IN-27|177028-90-9|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:44抑制剂Ac-CoA Synthase Inhibitor1|Ac-CoA Synthase Inhibitor1|508186-14-9|Adamas life|≥98%（以实测数值为准）|BR|5m
- 2024-08-20 01:44抑制剂Ac-DEVD-CHO|Ac-DEVD-CHO|169332-60-9|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:44抑制剂Ac-DEVD-CHO|Ac-DEVD-CHO|169332-60-9|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:44抑制剂Ac-DEVD-CHO|Ac-DEVD-CHO|169332-60-9|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:44抑制剂Acalisib|Acalisib|870281-34-8|Adamas life|≥98%（以实测数值为准）|BR|100mg
